Here, we first time found that the number of CD8+ TRM cells is significantly increased in the BM of DN-CML patients accompanied by a higher expression of TIGIT and PD-1, however, patients who received TKI treatment not shown the same pattern. The gene discussed is CD8A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.